Cerebral oximetry determination of desaturation with norepinephrine administration may be device manufacturer specific

Anesthesiology

Volumn 118, Issue 4, 2013, Pages 982-

  Grocott, Hilary P ^a   Davie, Sophie N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

BLOOD OXYGEN TENSION; BRAIN OXYGEN TENSION; CEREBRAL OXIMETRY; COMMERCIAL PHENOMENA; CONTAMINATION; FRONTAL LOBE; HUMAN; ISCHEMIA; LETTER; MEDICAL LITERATURE; NEAR INFRARED SPECTROSCOPY; OXIMETRY; OXYGEN DESATURATION; PRIORITY JOURNAL; SKIN BLOOD FLOW; TISSUE OXYGENATION; VASOCONSTRICTION;

BRAIN; HUMANS; MALE; NOREPINEPHRINE; SKIN; SPECTROSCOPY, NEAR-INFRARED; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84875901993     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182874672     Document Type: Letter

References (2)

1. Sørensen H, Secher NH, Siebenmann C, Nielsen HB, Kohl-Bareis M, Lundby C, Rasmussen P: Cutaneous vasoconstriction affects near-infrared spectroscopy determined cerebral oxygen saturation during administration of norepinephrine. Anesthesiology 2012; 117:263-70
2. Davie SN, Grocott HP: Impact of extracranial contamination on regional cerebral oxygen saturation: A comparison of three cerebral oximetry technologies. Anesthesiology 2012; 116:834-40